OBJECTIVE: To identify variables and evaluate methods for assessing chronic pain in dogs. DESIGN: Prospective study. ANIMALS: 41 dogs with canine hip dysplasia (CHD), and 24 apparently healthy dogs with no history of pain. PROCEDURE: 2 veterinarians evaluated the dogs' locomotion and signs of pain. Owners of dogs with CHD and control dogs answered a questionnaire regarding their dogs' demeanor, behavior, and locomotion (descriptive scales) and assessed pain and locomotion (visual analog scales). Plasma concentrations of several stress-related hormones were determined, and 13 radiologic variables were assessed in affected hip joints. RESULTS: For many of the questions, answers provided by owners of dogs with CHD differed significantly from those of owners of control dogs. Stress hormone concentrations differed significantly between dogs with CHD and controls, but individual variation was too great for them to be of value in pain assessment. None of the radiologic variables examined correlated well with owner or veterinarian pain scores. CONCLUSIONS AND CLINICAL RELEVANCE: Chronic pain could be assessed in dogs with CHD through completion of the study questionnaire by a person familiar with the pet (eg, owner) after receiving appropriate education in its use. Eleven variables were identified as being potentially useful in assessment of chronic pain in dogs.
OBJECTIVE: To identify variables and evaluate methods for assessing chronic pain in dogs. DESIGN: Prospective study. ANIMALS: 41 dogs with caninehip dysplasia (CHD), and 24 apparently healthy dogs with no history of pain. PROCEDURE: 2 veterinarians evaluated the dogs' locomotion and signs of pain. Owners of dogs with CHD and control dogs answered a questionnaire regarding their dogs' demeanor, behavior, and locomotion (descriptive scales) and assessed pain and locomotion (visual analog scales). Plasma concentrations of several stress-related hormones were determined, and 13 radiologic variables were assessed in affected hip joints. RESULTS: For many of the questions, answers provided by owners of dogs with CHD differed significantly from those of owners of control dogs. Stress hormone concentrations differed significantly between dogs with CHD and controls, but individual variation was too great for them to be of value in pain assessment. None of the radiologic variables examined correlated well with owner or veterinarian pain scores. CONCLUSIONS AND CLINICAL RELEVANCE: Chronic pain could be assessed in dogs with CHD through completion of the study questionnaire by a person familiar with the pet (eg, owner) after receiving appropriate education in its use. Eleven variables were identified as being potentially useful in assessment of chronic pain in dogs.
Authors: Pascale Rialland; Sylvain Bichot; Bertrand Lussier; Maxim Moreau; Francis Beaudry; Jérôme R E del Castillo; Dominique Gauvin; Eric Troncy Journal: Can J Vet Res Date: 2013-01 Impact factor: 1.310
Authors: Anna Hielm-Björkman; Riitta-Mari Tulamo; Hanna Salonen; Marja Raekallio Journal: Evid Based Complement Alternat Med Date: 2007-10-25 Impact factor: 2.629
Authors: Anna Hielm-Björkman; Riitta-Mari Tulamo; Hanna Salonen; Marja Raekallio Journal: Evid Based Complement Alternat Med Date: 2007-10-29 Impact factor: 2.629
Authors: Anna Hielm-Björkman; Johanna Roine; Kari Elo; Anu Lappalainen; Jouni Junnila; Outi Laitinen-Vapaavuori Journal: BMC Vet Res Date: 2012-09-06 Impact factor: 2.741
Authors: Vladimir Galindo-Zamora; Verena von Babo; Nina Eberle; Daniela Betz; Ingo Nolte; Patrick Wefstaedt Journal: BMC Vet Res Date: 2016-01-25 Impact factor: 2.741